Prothrombin Time International Normalized Ratio

Patient presents today for evaluation and management of their prothrombin time international normalized ratio (PT INR).  The patient reports [reason for INR check, e.g., routine monitoring of warfarin therapy, pre-operative assessment, investigation of bleeding or bruising].  Current medications include [list all medications including dosage and frequency, specifically noting anticoagulants like warfarin, Coumadin, DOACs, or antiplatelet agents].  Relevant medical history includes [mention relevant conditions like atrial fibrillation, deep vein thrombosis, pulmonary embolism, mechanical heart valve, liver disease, or any history of bleeding disorders].  Physical examination revealed [note any relevant findings such as bruising, petechiae, or other signs of bleeding or thromboembolism].  Laboratory results show a PT INR of [insert value].  Assessment: The patient's PT INR is [interpret the INR value: e.g., within therapeutic range, subtherapeutic, supratherapeutic].  This result is discussed with the patient.  Plan:  [Outline plan based on INR value. Examples:  If supratherapeutic, consider holding warfarin dose, vitamin K administration, and repeat INR monitoring.  If subtherapeutic, consider increasing warfarin dose and repeat INR monitoring.  If within therapeutic range, continue current warfarin dose and routine monitoring per established protocol]. Patient education provided regarding importance of medication adherence, dietary considerations with warfarin, and signs and symptoms of bleeding or clotting complications.  Follow-up appointment scheduled for [date] to re-evaluate PT INR and adjust therapy as needed.  ICD-10 code [appropriate code, e.g., Z72.83 for long-term use of anticoagulants] is considered for this encounter.